Volume 3.24 | Jun 24

Immunology of Infectious Disease News 3.24 June 24, 2015
Immunology of Infectious Disease News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Like Us on Facebook   IIDN on Twitter
 
TOP STORY
Scientists Show AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
Researchers showed in mice that an experimental vaccine candidate can stimulate the immune system activity necessary to stop HIV infection. The findings could provide key information for the development of an effective AIDS vaccine. [Press release from The Scripps Research Institute discussing online publication in Cell] Press Release | Full Article | Graphical Abstract
It all starts with the right cells! Access a range of fresh and frozen human primary cells.
 
PUBLICATIONS (Ranked by impact factor of the journal)
A Mucosal Vaccine against Chlamydia trachomatis Generates Two Waves of Protective Memory T Cells
Scientists describe a C. trachomatis (Ct) vaccine composed of ultraviolet light–inactivated Ct (UV-Ct) conjugated to charge-switching synthetic adjuvant nanoparticles (cSAPs). After immunizing mice with live Ct, UV-Ct, or UV-Ct–cSAP conjugates, they characterized mucosal immune responses to uterine Ct rechallenge and dissected the underlying cellular mechanisms. [Science] Abstract | Press Release

Chronic Morphine and HIV-1 Tat Promote Differential Central Nervous System Trafficking of CD3+ and Ly6C+ Immune Cells in a Murine Streptococcus pneumoniae Infection Model
Researchers explored the role of opportunistic systemic infection with S. pneumoniae in the recruitment of peripheral leukocytes into the central nervous system and its contribution to HIV-1-associated neurocognitive disorders in opioid-dependent individuals. [J Neuroinflamm] Abstract | Full Article

Measles Virus Hemagglutinin Triggers Intracellular Signaling in CD150-Expressing Dendritic Cells and Inhibits Immune Response
Researchers analyzed the effect of measles virus hemagglutinin interaction with CD150-expressing dendritic cells (DCs) on the DC signaling pathways and consequent phenotypic and functional changes in the absence of infectious context. [Cell Mol Immunol] Abstract

HIV

HIV-1 Neutralizing Antibodies Induced by Native-Like Envelope Trimers
Investigators showed that a soluble recombinant HIV-1 envelope glycoprotein trimer that adopts a native conformation (BG505 SOSIP.664) induced neutralizing antibodies potently against the sequence-matched Tier-2 virus in rabbits and similar but weaker responses in macaques. [Science] Abstract | Press Release

Cellular Immune Correlates Analysis of an HIV-1 Preexposure Prophylaxis Trial
Researchers showed that HIV-1–specific T-cell immunity can be detected in exposed but uninfected individuals and that these T-cell responses can differentiate individuals according to infection outcomes. [Proc Natl Acad Sci USA] Abstract | Full Article | Press Release

Cocaine-Mediated Impact on HIV Infection in Humanized BLT Mice
Scientists infected humanized mice with HIV-1 following acute cocaine exposure to assess the impact on infection. Stimulant exposure resulted in increased inflammatory cytokine expression, accelerated HIV infection, while blunting effector function of cytotoxic T lymphocytes. [Sci Rep] Full Article | Press Release

Spontaneous HIV Controllers Exhibit Preserved Immune Parameters in Peripheral Blood and Gastrointestinal Mucosa
Investigators found that HIV controllers have a conserved frequency of most immune cell populations in peripheral blood and gut associated lymphoid tissue, but a reduced percentage of CD4+ T cells. [JAIDS] Abstract

A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops
The basis for HIV-1’s initial dependence on CCR5, the selective force(s) that drive CXCR4-utilization, and the evolutionary pathways by which it occurs are incompletely understood. The authors describe five clonal variants with identical V3 loops but divergent CXCR4 use. [PLoS One] Full Article | Press Release

Subscribe to our sister publications: Human Immunology News and Immune Regulation News!

Free Nature Reviews Immunology Poster: The Immune Response to HIV
 
REVIEWS
BLT Humanized Mice as a Small Animal Model of HIV Infection
Investigators describe recent advances and applications of the BLT humanized mouse model of HIV infection and discuss opportunities to further improve this valuable small animal model. [Curr Opin Virol] Abstract

Cell Based Gene Therapy against HIV
The authors briefly discuss previous landmark studies on engineering stem cells or T cells that have been explored for therapeutic efficacy against HIV. They also analyze potential benefits and pitfalls of some studies done recently and will share their opinion on emerging trends. [Gene Ther] Abstract

Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field.
 
INDUSTRY NEWS
Important Advance in the Treatment and Prevention of Bacterial Infection
A new technology which could increase protection against antibacterial and antifungal infection for weeks, months or years has been developed by researchers at the University of Bristol. [University of Bristol] Press Release

Tekmira Provides Update on TKM-Ebola-Guinea
Tekmira Pharmaceuticals Corporation announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed. The endpoint indicated that continuing enrollment was not likely to demonstrate an overall therapeutic benefit. [Tekmira Pharmaceuticals Corporation] Press Release

From our sponsor: Studying ESCs or iPSCs? Request your free copy of the small molecules wallchart.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Cell Symposium: Human Immunity and the Microbiome in Health and Disease
September 27-29, 2015
Montreal, Canada

Visit our events page to see a complete list of events in the immunology of infectious disease community.
 
JOB OPPORTUNITIES
NEW Principal Investigator (Infectious Disease Research Institute)

NEW Faculty Positions – Immunology/Infectious Disease (The Wistar Institute)

Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)

Scientific Marketing Specialist – Immunology (STEMCELL Technologies Inc.)

Senior Scientist – Immunology Research (Bavarian Nordic GmbH)

Postdoctoral Scientist – HIV Immunology (Gilead Sciences)

PhD Position – Molecular Immunology (VIB – Ghent University)

Postdoctoral Fellow – Immune Tolerance (Stanford University)

PhD Position – Microbial Immunology (Hans Knöll Institute)

Principal Investigator – Virology and Immunology (Chinese Academy of Sciences)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Immunology of Infectious Disease News: Archives | Events | Contact Us